Connect with us

International Circuit

BioIQ & Matrix Medical Network Unveil Back-To-Work COVID-19 Testing Program For US Employers

BioIQ, a healthcare engagement and clinical adherence technology platform company, and Matrix Medical Network, a clinical leader in supporting the needs of at-risk populations, announce the availability of a COVID-19 testing, testing protocol, assessment and monitoring program for US employers as the country lays out plans to bring employees back to work. With clinical oversight provided by Matrix’s national array of locally based providers paired with BioIQ’s comprehensive technology and testing platform, the two companies provide a robust solution that is designed to protect workers as the US readies for its first steps in re-opening the country.

To keep employees safe and provide a framework of confidence for employers, the BioIQ and Matrix offering includes multiple workflows that enable COVID-19 testing at employer locations around the country, as well as community, retail, and drive-through testing sites. Joint capabilities include:

  • a COVID-19 testing platform and integrated lab network, including RT-PCR SARS-CoV-2 diagnostic testing and quantitative lab-based IgM/IgG antibody testing
  • CDC-driven virtual assessments for testing eligibility
  • a national network of over 3,000 clinicians
  • availability of onsite state-of-the-art mobile health clinics
  • on-premises fever and symptom checking
  • telehealth clinical guidance
  • employee population analytics, inclusive of social determinant of health (SDOH) data
  • omni-channel employee engagement and navigation tools

“We recognize that different employers and industries require different solutions to get their particular populations back to work,” said BioIQ CEO Justin Bellante. “Working in concert with Matrix, our Public Health Advisory Board, and leading epidemiologists, BioIQ has developed testing protocols for healthcare workers, emergency responders, critical infrastructure, and specific industries—including retail, manufacturing, food services, transportation, logistics, power, and technology—to meet their specific needs.”

Beyond simple one-size-fits-all testing, the BioIQ platform in combination with Matrix’s robust national clinical network, provides a solution for getting back to work immediately and keeping employees safe and productive at work as the pandemic evolves over the coming months and quarters. In accordance with CDC, state, and local guidelines, prioritization remains on healthcare workers, essential infrastructure, and vulnerable populations.

“Matrix is proud to partner with BioIQ to bring the most comprehensive clinical support and services to employers,” said Keith Henthorne, Matrix Chairman and CEO. “Running a business during a pandemic presents many unique challenges, especially for companies with a densely-concentrated workforce such as those with distribution centers and manufacturing facilities. Utilizing our national network of providers, Matrix is collaborating with employers to apply practices to keep employees safe and operations productive. Our on-site clinical staff can quickly identify and manage at-risk employees and, with BioIQ’s COVID-19 testing platform, help them stay safe and healthy.”

BioIQ and Matrix have partnered based on the organizations’ shared goal of improving outcomes through the convenient delivery of care where individuals live and work. As urgency to bring employees back to work mounts, these consequential offerings offer employers specific guidance on how to do so safely and effectively. To learn more about the back-to-work COVID-19 testing solution or broader employer health and wellness solutions and partnership, contact BioIQ at 888-818-1594 or at https://www.bioiq.com/covid-19-solution/, or contact Matrix at 877-564-3627 or www.matrixmedicalnetwork.com.-Bio Space

Copyright © 2024 Medical Buyer

error: Content is protected !!